Yesterday, Vitestro participated as a finalist in the ADLM Disruptive Technology Award Competition! Our CEO & co-founder Toon Overbeeke presented Vitestro and our technology in the final round. This award celebrates companies that are developing new innovative diagnostic tools and technologies to improve patient care, and we're proud to have made it to the final. We would like to congratulate Mercy BioAnalytics, Inc. with winning this competition! We are also excited to announce that Vitestro won the People’s Choice Award. We are at our booth (#3971) at ADLM in Chicago until Thursday. We're eager to learn more about the needs of US laboratories and to hear your thoughts on our device. If you're attending the conference, don't forget to stop by and chat with us! Looking forward to connecting with many of you at ADLM! #Vitestro #ADLM2024 #DTAC
Vitestro
Productie medische apparatuur
Utrecht, Utrecht 4.518 volgers
We transform patient care with autonomous blood drawing technology
Over ons
Vitestro will be the first to bring autonomous blood drawing technology to European hospitals. Blood drawing, performed billions of times per year worldwide, is key to clinical diagnosis. Given a growing population and shortages of healthcare personnel, there is a clear need for a future-proof system to keep up with demand for diagnostics.
- Website
-
http://www.vitestro.com
Externe link voor Vitestro
- Branche
- Productie medische apparatuur
- Bedrijfsgrootte
- 51 - 200 medewerkers
- Hoofdkantoor
- Utrecht, Utrecht
- Type
- Particuliere onderneming
- Opgericht
- 2017
- Specialismen
- autonomous blood-drawing device, pre-analytical, phlebotomy, venipuncture, venapuncture, medical device en precision robotics
Locaties
-
Primair
Europalaan 500
Utrecht, Utrecht 3526KS, NL
Medewerkers van Vitestro
-
Wim Domburg
SW Project Manager for development of Vitestro's Autonomous Blood Puncturing device
-
Maxine Moor
Business leader | Board Member | Wingman of CEO | Transformational leader | CCO | Servitization Expert | passionate about creating recurring…
-
Rogier Van Sterkenburg
Software Engineer at Vitestro
-
Esther Crena Uiterwijk
Updates
-
#TeamUpdate We are thrilled to welcome Zakaria Tazi Hnyine, who joined us last month as our new Strategic Projects Manager in the general team at Vitestro! Zakaria brings a robust analytical background in Mechanical Engineering and over 5 years of strategy consulting experience at McKinsey. He has successfully supported more than 13 management boards in driving diverse strategies and executing large-scale corporate transformations. With his diverse skill set and expertise, Zakaria is excited to contribute to Vitestro, and so are we! #BloodDrawPioneers #BloodDraw #Phlebotomy #MedTech #Innovation #NewHire #Career #News #NewTeamMemberAlert #Vitestro
-
-
#TeamUpdate We're excited to introduce yet another new team member who joined us just last month – Rene van Maarschalkerweerd! With 30+ years of experience in the field of financial administration, we are proud to add Rene to our Finance team in this phase of exponential growth! Join us in giving Rene a warm welcome! #BloodDrawPioneers #BloodDraw #Phlebotomy #MedTech #Innovation #NewHire #Career #News #NewTeamMemberAlert #Vitestro
-
-
Thank you Helena! [English] What is it like to have blood drawn by a machine? Nearly 200 volunteers tried it out at Amsterdam UMC as part of the A.D.O.P.T. study. This study will teach us a lot about the technical and clinical performance of the autonomous blood-drawing device developed by Vitestro. Such curiosity and enthusiasm for this innovation! Many thanks for the wonderful collaboration over the past 4 weeks! #Vitestro #Bloedafname #MedTech
Hoe is het om bloed te laten afnemen door een apparaat? Bijna 200 vrijwilligers probeerden dat uit in het Amsterdam UMC in het kader van de A.D.O.P.T. studie. Deze studie gaat ons veel leren over de technische en klinische prestaties van het autonome bloedafname apparaat ontwikkeld door Vitestro Wat een nieuwsgierigheid en enthousiasme voor deze innovatie! Heel veel dank voor de mooie samenwerking in de afgelopen 4 weken! Frédérique Koopman Jeroen Roest Luuk Giesen Marjory de Getrouwe-Rosheuvel Lisa Rutten Luc Romkes Robert de Jonge
-
-
#TeamUpdate We’re excited to welcome Karin Dijkstra to the Vitestro team! She joined our Mechatronics & Industrialization team as our new Mechanical Engineer. With 15 years of experience in developing diverse products, from medical devices to aviation technology. Karin is even specialized in building fixed-wing drones. We trust Karin to help Vitestro in all aspects of the design, engineering and testing of our amazing blood drawing device. #BloodDrawPioneers #BloodDraw #Phlebotomy #MedTech #Innovation #Career #Vitestro
-
-
Vitestro heeft dit gerepost
A.D.O.P.T. Trial Results @ Worldlab It’s been a great couple of days for the Vitestro team at IFCC WorldLab 2024, where we publicly shared results from the A.D.O.P.T. trial. We are proud to report that all performance and safety endpoints were met in the A.D.O.P.T. Pivotal Trial phase. Other key findings include a 95% first-stick success rate and 98% patient acceptance. In the words of Thijs Van Holten, one of the study's Principal Investigators, “These results clearly demonstrate the potential for this new way of managing blood draws using advanced technologies.” The A.D.O.P.T. trial (NCT05878483) is scheduled to run through 2025 and involves 10,000 patients over five study phases. It is the largest evaluation of autonomous blood drawing devices in the world. Thank you to our study partners, St. Antonius Ziekenhuis, OLVG Lab BV, Result Laboratorium, and Amsterdam UMC for the great collaboration. We look forward to continuing the A.D.O.P.T. trial! Please check out the link below to see more details and to download the study results. https://lnkd.in/eGyhWwjE
-
A.D.O.P.T. Trial Results @ Worldlab It’s been a great couple of days for the Vitestro team at IFCC WorldLab 2024, where we publicly shared results from the A.D.O.P.T. trial. We are proud to report that all performance and safety endpoints were met in the A.D.O.P.T. Pivotal Trial phase. Other key findings include a 95% first-stick success rate and 98% patient acceptance. In the words of Thijs Van Holten, one of the study's Principal Investigators, “These results clearly demonstrate the potential for this new way of managing blood draws using advanced technologies.” The A.D.O.P.T. trial (NCT05878483) is scheduled to run through 2025 and involves 10,000 patients over five study phases. It is the largest evaluation of autonomous blood drawing devices in the world. Thank you to our study partners, St. Antonius Ziekenhuis, OLVG Lab BV, Result Laboratorium, and Amsterdam UMC for the great collaboration. We look forward to continuing the A.D.O.P.T. trial! Please check out the link below to see more details and to download the study results. https://lnkd.in/eGyhWwjE
Pivotal Trial Study Of Breakthrough Autonomous Blood Draw Technology Confirms Performance, Safety and Patient Acceptance | Vitestro
https://vitestro.com
-
Vitestro heeft dit gerepost
🔎 Voor Vitestro ben ik op zoek naar een JUNIOR COMMERCIAL OPERATIONS MANAGER In deze rol ga je > Ondersteunen bij sales-activiteiten en business development dmv het maken van sales-pitches en overtuigende businesscases. > Onze commerciële afdeling helpen bij het opstellen en verfijnen van workflows. > Rapportages maken over de operationele voortgang ter ondersteuning van strategische besluitvorming. 👣 Deze rol zou goed passen bij iemand die toe is aan de tweede stap. Iemand met een paar jaar ervaring als associate bij een consultancy firm of als inside sales bij een commerciële partij. 📊 Het is een spannende rol voor iemand die houdt van cijfers en data analyse en van het maken van strakke presentaties. Je gaat werken met onze strateeg en de VP Sales & Marketing Europe. 💉 Vitestro gaat de wereld van de zorg ingrijpend veranderen met de ontwikkeling van een volledig autonome bloedafname-robot en heeft de documenten ter goedkeuring bij de FDA en EMA ingediend. Daarnaast is er onlangs $20mio in het bedrijf geïnvesteerd. Een spannende en opwindende tijd en een mooi moment om je bij ons aan te sluiten! 💰Wij bieden een ambitieuze en getalenteerde werkomgeving waar belang wordt gehecht aan jouw persoonlijke ontwikkeling en groei. Daarom is er een flink budget voor jouw zelfontplooiing. Natuurlijk word je goed beloond en is equity een deel van je pakket. 🔘 Solliciteren kan snel via de button in de job. Niet voor jou? Voel je vrij om deze post te delen. #sales #salesoperations #businessdevelopment #juniorsales
-
As if the month of May wasn’t exciting enough… We’re proud to share: In a first international pre-order for Vitestro, the Danish Odense University Hospital pre-orders 3 blood drawing devices. This exciting collaboration coming from Odense (labelled ‘the world’s best robot city’) is showing a global need for the Vitestro solution. For our Danish connections: Going to the Hospital Automation Summit in Odense this week (Odense Robotics)? Join Wessel van Dijk presenting the future of phlebotomy at the summit and come see us at our booth! Read more at: https://lnkd.in/evv8ZuaK #Vitestro #Odense #Phlebotomy #Innovation
Danish hospital pre-orders 3 blood drawing devices, in first international deployment for Vitestro. | Vitestro
https://vitestro.com
-
Vitestro heeft dit gerepost
As special guest at Lucien Engelen's keynote speech at ICT&health, Toon Overbeeke had a surprise for the audience as he shared his vision for the future of autonomous phlebotomy: 💡 For the first time ever a demonstration of the Vitestro device was given live on stage, featuring our vein finding technology! Other exciting keynotes were given by John Halamka, M.D., M.S. (Mayo Clinic), Helen Mertens (Maastricht UMC) and Bianca Rouwenhorst (Dutch Ministry of Health). Stay tuned for more exciting news in the coming weeks! #Vitestro #ICTHealth #Phlebotomy #Maastricht
-